Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Buy
21,893
+11,883
+119% +$1.44M 0.01% 1106
2026
Q1
$1.64M Sell
10,010
-11,752
-54% -$1.81M 0.01% 1167
2025
Q4
$3.79M Buy
21,762
+20,113
+1,220% +$3.67M 0.01% 875
2025
Q3
$237K Buy
+1,649
New +$202K ﹤0.01% 1569

Other funds holding INSM

Joel Greenblatt's INSM Position: Q2 2026 in Review

Joel Greenblatt increased its Insmed (INSM) stake by 119% in Q2 2026, buying an estimated $1.44M and bringing the position to 21,893 shares worth $2.33M. The position accounts for 0.01% of the portfolio, ranked #1106.

Joel Greenblatt first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.79M in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Joel Greenblatt held 21,893 shares of Insmed worth $2.33M as of Q2 2026.
  • Joel Greenblatt bought 11,883 Insmed shares in Q2 2026, an estimated $1.44M.
  • Insmed made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1106 holding.
  • Joel Greenblatt first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Joel Greenblatt's Insmed position peaked at $3.79M in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.